Although IL-1β was described to be a major proinflammatory mediator in children with nephrotic syndrome and in animal models of nephrosis [30–32], in the present study no variations were observed in IL-1β expression levels in PAN-treated rats compared to the control group. Here, IL1B is linked to polyarteritis nodosa.